Evidence map›Paper›PMID 20018733›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2009

Activation of EGFR on monocytes is required for human cytomegalovirus entry and mediates cellular motility.

Gary Chan, Maciej T Nogalski, Andrew D Yurochko

Open access · greenAbstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 131 papers.

0numbers the graph read from it
0cells of the map it votes in
131citing papers in PubMed
5.2field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

131 citing papers in PubMed, 197 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Does human cytomegalovirus provide a novel therapeutic target for patients with glioblastoma?Philosophical transactions of the Royal Society of London. Series B, Biological sciences · 2025
    Review
  5. Review
  6. Article
  7. Article
  8. Article
  9. Review
  10. Review
  11. Article
  12. Article
  13. Distinct early role of PTEN regulation during HCMV infection of monocytes.Proceedings of the National Academy of Sciences of the United States of America · 2024
    Article
  14. Article
  15. Mcl-1 Protein and Viral Infections: A Narrative Review.International journal of molecular sciences · 2024
    Review
  16. Article
  17. Human cytomegalovirus and neonatal infection.Current research in microbial sciences · 2024
    Review
  18. Review
  19. Article
  20. Amphiregulin couples IL1RL1Science advances · 2023
    Article

71 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Gary ChanDepartment of Microbiology and Immunology, Center for Molecular and Tumor Virology, Louisiana State University Health Sciences Center, Shreveport, LA 71130-3932, USA.
Maciej T Nogalski
Andrew D Yurochko
Louisiana State University Health Sciences Center Shreveport · US

Funding

RECRUITMENT YEAR FOR PI#5P20RR018724 · NCRR · LOUISIANA STATE UNIV HSC SHREVEPORT · PI TSUNODA, IKUO · 2003 to 2011
$16.1M
Analysis of HCMV Infection of Monocytes and MacrophagesR01AI056077 · NIAID · LOUISIANA STATE UNIV HSC SHREVEPORT · PI YUROCHKO, ANDREW D · 2004 to 2020
$4.7M
COBRE Center for Molecular and Tumor VirologyP20GM103433 · NIGMS · LOUISIANA STATE UNIV HSC SHREVEPORT · PI O'CALLAGHAN, DENNIS JOHN · 2012 to 2012
$1.9M
Human Cytomegalovirus-Induced Inhibition of Cytotrophoblast InvasionR01HD051998 · NICHD · TULANE UNIVERSITY OF LOUISIANA · PI MORRIS, CINDY ANNE · 2008 to 2012
$1.5M
NCRR NIH HHS 1-P20-RR018724NCRR NIH HHS P20 RR018724NIAID NIH HHS AI56077NIAID NIH HHS R01 AI056077NICHD NIH HHS HD051998NICHD NIH HHS R01 HD051998NIGMS NIH HHS P20 GM103433
6 · The paper itself

Abstract

Human cytomegalovirus (HCMV) rapidly induces a mobile and functionally unique proinflammatory monocyte following infection that is proposed to mediate viral spread. The cellular pathways used by HCMV to initiate these biological changes remain unknown. Here, we document the expression of the epidermal growth factor receptor (EGFR) on the surface of human peripheral blood monocytes but not on other blood leukocyte populations. Inhibition of EGFR signaling abrogated viral entry into monocytes, indicating that EGFR can serve as a cellular tropism receptor. Moreover, HCMV-activated EGFR was required for the induction of monocyte motility and transendothelial migration, two biological events required for monocyte extravasation into peripheral tissue, and thus viral spread. Transcriptome analysis revealed that HCMV-mediated EGFR signaling up-regulated neural Wiskott-Aldrich syndrome protein (N-WASP), an actin nucleator whose expression and function are normally limited in leukocytes. Knockdown of N-WASP expression blocked HCMV-induced but not phorbol 12-myristate 13-acetate (PMA)-induced monocyte motility, suggesting that a switch to and/or the distinct use of a new actin nucleator controlling motility occurs during HCMV infection of monocytes. Together, these data provide evidence that EGFR plays an essential role in the immunopathobiology of HCMV by mediating viral entry into monocytes and stimulating the aberrant biological activity that promotes hematogenous dissemination.

Indexed as

Virus InternalizationCell MovementCytomegalovirusCytomegalovirus InfectionsEndothelium, VascularErbB ReceptorsGene Expression ProfilingHost-Pathogen InteractionsHumansIn Vitro TechniquesMonocytesPhosphorylationTetradecanoylphorbol AcetateUp-RegulationWiskott-Aldrich Syndrome Protein, NeuronalErbB ReceptorsTetradecanoylphorbol AcetateWASL protein, humanWiskott-Aldrich Syndrome Protein, Neuronal

Identifiers

PMID20018733
PMCPMC2799688
OpenAlexW2040101892

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.